TORONTO–(BUSINESS WIRE)–Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF) (the “Company“), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, announces that it is extending the expiry date (the “Warrant Extension”) and amending the exercise price (the “Amended Exercise Price”) of 3,117,957 common share purchase warrants (“Warrants”) of … [Read more…]
Q3/22 revenue increased over 225% quarter-over-quarter, and more than 4,800% year-over-year; Mednow patient count increased by approximately 20% to ~23,000 in Q3 versus ~19,000 in Q2; In the 2022 calendar year, revenue is forecasted to range between C$42.5M and C$47.5M; approximately C$42M will come from its pharmacy services, while approximately C$3M will come from doctor … [Read more…]
Now available in eye clinics across 49 states and Puerto Rico, each new partnership increases access to Nanodropper’s value-based care solution for reducing the size of prescription eye drops while also extending the life of the medication ROCHESTER, Minn.–(BUSINESS WIRE)–#MedicalDevice—Nanodropper, a patient-centered, volume-reducing adaptor for eyedrop bottles, announces major growth metrics over the last 12 … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Kits Market Share, Size, Trends, Industry Analysis Report, By Service , By Phase , By Region; Segment Forecast, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global clinical trial kits market is anticipated to grow up to USD 2.85 billion by 2030 according to a new study. The … [Read more…]
A comprehensive ankle plating portfolio, designed with the proven technology of Arsenal Foot Plating System, expands offerings to address both tri-malleolar and intra-articular fracture patterns WILMINGTON, Del.–(BUSINESS WIRE)–DJO® is now part of the Enovis™ family.* Enovis Corporation, an innovation-driven medical technology growth company, announced today the launch of the Arsenal Ankle Plating System™. This system … [Read more…]
Shionogi and NHS England have signed an agreement to begin an innovative subscription payment model for reimbursement of cefiderocol in England which ‘de-links’ payment from volume of use1 Shionogi recognises the UK’s leadership role in introducing the world’s first fully ‘delinked’ pilot reimbursement model; pull incentives like this are an important step in making the … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Disposable Masks – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. The global market for Disposable Masks estimated at US$20 Billion in the year 2020, is projected to reach a revised size of US$26.6 Billion by 2026, growing at a CAGR of 5.4% over the analysis period. Surgical Masks, … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Synthetic Biology Market Research Report by Tool (Chassis Organisms, Cloning Technology Kits, and Enzymes), Technology, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Synthetic Biology Market size was estimated at USD 16.95 … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Single Cell Analysis Market Research Report by Product (Consumables and Instruments), Technology, Process, Application, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Single Cell Analysis Market size was estimated at USD 5,111.60 … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Axial Spondyloarthritis Market – A Global and Country Analysis: Focus on Commercialized Therapies, Potential Pipeline Products, Indication, and Country – Analysis and Forecast, 2022-2032” report has been added to ResearchAndMarkets.com’s offering. The global axial spondyloarthritis market was estimated to be at $1,873.8 million in 2021, which is expected to grow with a CAGR … [Read more…]
